BOLTON SECURITIES CORPORATION’s Inovio Pharmaceuticals INO Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$339	Buy	+208	New	+$417	﹤0.01%	1825

Other funds holding INO

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's INO Position: Q1 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Inovio Pharmaceuticals (INO) in Q1 2025: 208 shares worth $339. The stake represents ﹤0.01% of the portfolio and ranks #1825 among its holdings.

110 funds tracked by Wall St. Rank hold INO as of Q1 2025.

BOLTON SECURITIES CORPORATION held 208 shares of Inovio Pharmaceuticals worth $339 as of Q1 2025.
Inovio Pharmaceuticals was a new BOLTON SECURITIES CORPORATION position in Q1 2025.
Inovio Pharmaceuticals made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2025, its #1825 holding.
110 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2025, filed 12 Nov 2026.